Sign In
Buy OMER
$10.16
-0.1000 (-0.97%)
At Close: Jun 03, 2026
Omeros Clears Technical Benchmark, Hitting 80-Plus RS Rating
12:00am, Tuesday, 07'th Apr 2020Omeros Corporation: The Thesis Was Playing Out Before COVID-19 Hit
09:19pm, Tuesday, 31'st Mar 2020
We recommended Omeros on July 15 of last year when the stock was trading at $14.69/share. The stock spiked to almost $20/share on March 3 when great narsoplimab
Omeros (NASDAQ:OMER) Upgraded to Buy by Zacks Investment Research
09:30am, Tuesday, 31'st Mar 2020
Omeros (NASDAQ:OMER) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports. The brokerage curren
19,300 Shares in Omeros Co. (NASDAQ:OMER) Bought by Alberta Investment Management Corp
08:52am, Monday, 30'th Mar 2020
Alberta Investment Management Corp purchased a new position in shares of Omeros Co. (NASDAQ:OMER) in the fourth quarter, according to the company in its most recent disclosure with the Securities and
Credit Suisse AG Increases Stock Holdings in Omeros Co. (NASDAQ:OMER)
11:04am, Wednesday, 25'th Mar 2020
Credit Suisse AG raised its stake in Omeros Co. (NASDAQ:OMER) by 5.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 213,986 shares of the biopharmaceutical company’s stock afte
Omeros (NASDAQ:OMER) Upgraded by Zacks Investment Research to Buy
10:26am, Wednesday, 25'th Mar 2020
Omeros (NASDAQ:OMER) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. The
Omeros' Tumultuous March
01:07pm, Friday, 20'th Mar 2020
Omeros closed out Q4 2019 with an excellent earnings report. The company's Q4 earnings report showed its lead therapy, Narsoplimab, cruising to a near landing o
$30.92 Million in Sales Expected for Omeros Co. (NASDAQ:OMER) This Quarter
07:42am, Friday, 20'th Mar 2020
Wall Street brokerages expect that Omeros Co. (NASDAQ:OMER) will report $30.92 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Omeros�
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) …
Brokerages Set Omeros Co. (NASDAQ:OMER) Price Target at $26.75
09:06am, Saturday, 14'th Mar 2020
Shares of Omeros Co. (NASDAQ:OMER) have been given an average recommendation of “Hold” by the eight brokerages that are currently covering the company, Marketbeat reports. One equities research an
Omeros (NASDAQ:OMER) Stock Rating Upgraded by ValuEngine
08:00am, Thursday, 12'th Mar 2020
Omeros (NASDAQ:OMER) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Tuesday, ValuEngine reports. A number of other
Edited Transcript of OMER earnings conference call or presentation 2-Mar-20 9:30pm GMT
07:38pm, Wednesday, 11'th Mar 2020
Q4 2019 Omeros Corp Earnings Call
Edited Transcript of OMER earnings conference call or presentation 2-Mar-20 9:30pm GMT
02:25pm, Wednesday, 11'th Mar 2020
Q4 2019 Omeros Corp Earnings Call
Capital Impact Advisors LLC Boosts Position in Omeros Co. (NASDAQ:OMER)
10:28am, Wednesday, 11'th Mar 2020
Capital Impact Advisors LLC increased its holdings in shares of Omeros Co. (NASDAQ:OMER) by 23.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities &
Cantor Fitzgerald Research Analysts Increase Earnings Estimates for Omeros Co. (NASDAQ:OMER)
06:22am, Monday, 09'th Mar 2020
Omeros Co. (NASDAQ:OMER) – Research analysts at Cantor Fitzgerald upped their FY2020 earnings per share estimates for shares of Omeros in a research note issued to investors on Thursday, March 5th.
